Ikena Oncology Inc (IKNA) — Capital Reinvestment Ratio

Latest as of December 2019: 0.01x

Ikena Oncology Inc (IKNA) has a Capital Reinvestment Ratio of 0.01x as of December 2019, meaning it reinvests 0% of its operating cash flow ($47.93 Million) in capital expenditures ($316.00K). See Ikena Oncology Inc net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

$47.93 Million
USD

Capital Expenditures

$316.00K
USD

Data as of

Dec 2019
Most recent filing

Ikena Oncology Inc Capital Reinvestment Ratio (2019–2019)

This chart tracks Ikena Oncology Inc's Capital Reinvestment Ratio across 1 annual periods. Check Ikena Oncology Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Ikena Oncology Inc (2019–2019)

Year-by-year Capital Reinvestment Ratio for Ikena Oncology Inc from 2019 to 2019. For live market cap and broader valuation context, see IKNA stock market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2019 0.01x $47.93 Million $316.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow